COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UM1 AI068614
National Institutes of Health
Grant: UM1 AI068635
National Institutes of Health
Grant: UM1 AI069412
NIAID NIH HHS
Grant: R38 AI174306
NIAID NIH HHS
Grant: UM1 AI148450
NIAID NIH HHS
Grant: UM1 AI069423
NIAID NIH HHS
Grant: U01 AI069470
NIAID NIH HHS
Grant: UM1 AI069476
NCATS NIH HHS
Grant: UL1 TR001863
NIAID NIH HHS
Grant: UM1 AI148576
NIAID NIH HHS
Grant: UM1 AI148689
NIA NIH HHS
Grant: U54 AG062334
NIAID NIH HHS
Grant: UM1 AI069470
NIAID NIH HHS
Grant: UM1 AI148684
AIDS Clinical Trials Group
Vaccine Treatment and Evaluation Units
Biomedical Advanced Research and Development Authority
Infectious Diseases Clinical Research Consortium
HIV Prevention Trials Network
National Institute of Allergy and Infectious Diseases
US government
HIV Vaccine Trials Network
MeSH Terms
Keywords